Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -249.59%, near the high end of its 5-year range (-66200.00%–14.02%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-79.75%
NET PROFIT MARGIN AVG 5Y
-249.59%
NET PROFIT MARGIN AVG 10Y
-186.63%
NET PROFIT MARGIN AVG 15Y
-290.42%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Pulmatrix, Inc.
Market Cap
$5.22M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-79.75%
5Y Avg
-249.59%
Market Cap
$5.21M
Net Profit Margin
-106.78%
TTM Avg
-43.08%
3Y Avg
-12.30%
5Y Avg
-12.30%
Market Cap
$5.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.24M
Net Profit Margin
-294.91%
TTM Avg
-320.57%
3Y Avg
-453.36%
5Y Avg
-361.46%
Market Cap
$5.31M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1379.84%
5Y Avg
-7344.76%
Market Cap
$5.32M
Net Profit Margin
-4011.86%
TTM Avg
-2005.93%
3Y Avg
-2671.67%
5Y Avg
-1781.12%
Market Cap
$5.12M
Net Profit Margin
-612568.11%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.35M
Net Profit Margin
-3985.58%
TTM Avg
-1467.13%
3Y Avg
-2181.72%
5Y Avg
-1717.85%
Market Cap
$4.97M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.22M | 0.00% | 0.00% | -79.75% | -249.59% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.21M | -106.78% | -43.08% | -12.30% | -12.30% |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -294.91% | -320.57% | -453.36% | -361.46% |
| Soligenix, Inc. (SNGX)vs › | $5.31M | 0.00% | 0.00% | -1379.84% | -7344.76% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.32M | -4011.86% | -2005.93% | -2671.67% | -1781.12% |
| Lunai Bioworks Inc. (LNAI)vs › | $5.12M | -612568.11% | 0.00% | 0.00% | 0.00% |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.35M | -3985.58% | -1467.13% | -2181.72% | -1717.85% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $4.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $4.86M | -75.90% | -124.23% | -198.78% | -629.10% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -66200.00% |
| 2024-09-30 | -706.83% |
| 2024-06-30 | -374.42% |
| 2024-03-31 | 14.02% |
| 2023-12-31 | -94.60% |
| 2023-09-30 | -215.29% |
| 2023-06-30 | -206.94% |
| 2023-03-31 | -296.73% |
| 2022-12-31 | -246.84% |
| 2022-09-30 | -269.87% |
| 2022-06-30 | -345.23% |
| 2022-03-31 | -428.71% |
| 2021-12-31 | -883.99% |
| 2021-09-30 | -765.58% |
| 2021-06-30 | -170.90% |
| 2021-03-31 | -295.25% |
| 2020-12-31 | -144.95% |
| 2020-09-30 | -241.38% |
| 2020-06-30 | -33.43% |
| 2020-03-31 | -169.66% |
| 2019-12-31 | -239.82% |
| 2019-09-30 | -252.84% |
| 2019-06-30 | -162.77% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | -3412.42% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | -1328.96% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | -8401.71% |
| 2016-09-30 | -5175.41% |
| 2016-06-30 | -3533.46% |
| 2016-03-31 | -1431.57% |
| 2015-12-31 | -1649.45% |
| 2015-09-30 | -757.60% |
| 2015-06-30 | -8762.94% |
| 2015-03-31 | -1717.14% |
| 2014-12-31 | -814.01% |
| 2014-09-30 | -37113.33% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | -43925.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
